Original Research
Published on 31 May 2012
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2012.00056
- 6,342 views
- 13 citations